Citi Cuts Lucid Price Target as Q1 Miss Rocks Shares
Citi lowers Lucid's price target to $14 following a disappointing Q1 2026 and the withdrawal of 2026 guidance, while ...
Assess top-performing Hyd etfs for retirees, comparing yields, risk, and track records to help you choose a fund aligned with retirement goals.
27,995 articlesCiti lowers Lucid's price target to $14 following a disappointing Q1 2026 and the withdrawal of 2026 guidance, while ...
An insider sold 50,000 shares of Hinge Health, prompting questions about the stock’s outlook. This guide breaks down ...
When a Galicia director just bought a large stake, investors ask: is this a signal of confidence or a red flag? This ...
DSGR's Q4 2025 results sparked questions about growth, margins, and 2026 guidance. This deep dive explains what the n...
A significant share of women say their gender slows their progress, affecting careers and money. Learn practical stra...
A new class of startups installing tiny data centers is testing home-based compute nodes to relieve grid pressure and...
SpaceX lit up the market with a big debut, yet the price tag raised serious questions. This article breaks down why m...
As lenders chase ROI from AI, a governance-first pivot for mortgage workflows is gaining steam. Banks report better a...
As Omada Health eyes the 2025 earnings journey, investors want a clear read on growth, margins, and risks. This guide...
Micron just beat earnings, but the stock didn’t soar. This article breaks down what happened, how AI demand, margins,...
As the debate over earnings reporting evolves, good quarterly earnings behavior becomes a competitive edge. This guid...
The world’s second richest person title is a moving target as stock prices swing. Here's who holds it this week and w...